0001217234-21-000174.txt : 20210709
0001217234-21-000174.hdr.sgml : 20210709
20210709192834
ACCESSION NUMBER: 0001217234-21-000174
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210708
FILED AS OF DATE: 20210709
DATE AS OF CHANGE: 20210709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seeto Reginald
CENTRAL INDEX KEY: 0001688485
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36536
FILM NUMBER: 211083970
MAIL ADDRESS:
STREET 1: C/O ARDELYX, INC.
STREET 2: 34175 ARDENWOOD BLVD, SUITE 200
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CareDx, Inc.
CENTRAL INDEX KEY: 0001217234
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 943316839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 TOWER PLACE
STREET 2: 9TH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-287-2300
MAIL ADDRESS:
STREET 1: 1 TOWER PLACE
STREET 2: 9TH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: XDx, Inc.
DATE OF NAME CHANGE: 20071010
FORMER COMPANY:
FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC
DATE OF NAME CHANGE: 20030203
4
1
wf-form4_162587329843386.xml
FORM 4
X0306
4
2021-07-08
0
0001217234
CareDx, Inc.
CDNA
0001688485
Seeto Reginald
C/O CAREDX, INC.
1 TOWER PLACE, 9TH FLOOR
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
See Remarks
Common Stock
2021-07-08
4
S
0
1880
84.8746
D
136748
D
Common Stock
2021-07-08
4
S
0
2714
85.7367
D
134034
D
Common Stock
2021-07-08
4
S
0
1400
86.6069
D
132634
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.28 to $85.21, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.30 to $86.25, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.32 to $86.99, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
President and Chief Executive Officer
/s/ Reginald Seeto
2021-07-09